Armistice Capital, LLC 13D and 13G filings for FibroGen, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 5:49 pm Unchanged |
2024-12-31 | 13G | FibroGen, Inc. FGEN |
Armistice Capital, LLC | 6,800,000 6.750% |
0 (Unchanged) |
Filing |
| 2024-11-14 4:52 pm Sale |
2024-09-30 | 13G | FibroGen, Inc. FGEN |
Armistice Capital, LLC | 6,800,000 6.770% |
-2,964,000 (-30.36%) |
Filing |
| 2024-02-14 3:37 pm Purchase |
2023-12-31 | 13G | FibroGen, Inc. FGEN |
Armistice Capital, LLC | 9,764,000 9.930% |
9,764,000 (New Position) |
Filing |